About Mojia Biotech
Mojia Biotech is a company based in Shanghai (China) founded in 2017. Mojia Biotech has raised $80 million across 1 funding round from investors including Temasek, Sento.io and LYZZ Capital. Mojia Biotech offers products and services including Biomanufacturing Solutions and Green Feedstocks.
- Headquarter Shanghai, China
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Mojiabio
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$80 M (USD)
in 1 rounds
-
Latest Funding Round
$80 M (USD), Series B
Jun 22, 2022
-
Investors
Temasek
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mojia Biotech
Mojia Biotech offers a comprehensive portfolio of products and services, including Biomanufacturing Solutions and Green Feedstocks.
Develops sustainable chemical and agricultural additives via AI and engineering
Produces eco-friendly inputs for industrial applications using biology
Funding Insights of Mojia Biotech
Mojia Biotech has successfully raised a total of $80M through 1 strategic funding round. The most recent funding activity was a Series B round of $80 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mojia Biotech
Mojia Biotech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Temasek, Sento.io and LYZZ Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
A global healthcare-focused VC/PE firm is operated.
|
Locked | Locked | Locked | |
|
A venture capital firm focused on agriculture and food technology.
|
Locked | Locked | Locked |
Investor details for Mojia Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mojia Biotech
Investment portfolio details for Mojia Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mojia Biotech
Detailed financials for Mojia Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mojia Biotech Comparisons
Peer comparison for Mojia Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mojia Biotech
Detailed competitors of Mojia Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mojia Biotech
Complete news archive for Mojia Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mojia Biotech
Mojia Biotech was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Mojia Biotech is headquartered in Shanghai, China.
Indra Jones Santana is the current CEO of Mojia Biotech.
Mojia Biotech is a funded company, having raised a total of $80M across 1 funding round to date.
Mojia Biotech was established in 2017 in Shanghai, China, within the biotechnology sector. Additives for animal feed are produced as nutritional supplements. The Viridimin range, featuring vitamin B5 formulations, is supplied for integration into animal nutrition. Furthermore, Aliphane, a bio-polymer material, is manufactured for applications in coatings and adhesives. Core operations center on these product lines to support agricultural and industrial needs.
Mojia Biotech offers Biomanufacturing Solutions and Green Feedstocks.
Mojia Biotech has 5 investors. Key investors include Temasek, Sento.io, LYZZ Capital, Bits x Bites, and Asia Green Fund.